Roland Veltkamp

Roland Veltkamp studied medicine at RWTH Aachen Germany as well as in London, Paris, Zurich, Detroit and Winston-Salem, USA. In 1994 he started his specialty training in Neurology at the Department of Neurology University Munich which he Department of Neurology University Heidelberg in Germany. He worked as a postdoctoral fellow at Wake Forest University School of Medicine where he studied the experimental effects of oxygen in experimental cerebral ischemia. After his return to Heidelberg, Germany, he founded a research group in Translational Stroke that addressed the immunology of stroke as well as complications of oral anticoagulation. In 2013 he was appointed as a Professor of Neurology and the Chair of Stroke Medicine at Imperial College London. He served as the Head of Specialty for Stroke Medicine at Imperial College until 2017. In 2018 he became the Head of the Department of Neurology, Alfred-Krupp Krankenhaus Essen Germany., Prof Veltkamp has been active in the ESO as a member